The 2017 QS World University Rankings by Subject, released overnight, have placed Monash second in the world for pharmacy and pharmacology.
The new rankings mean that Monash continues to be number one in Australia and within the AsiaPacific region. It has averaged a top 10 ranking in the discipline since the subject rankings were introduced in 2011.
The ranking represents an improvement of two places on 2016, when Monash was ranked #4 behind Harvard University, The University of Cambridge and The University of Oxford. Harvard has retained the top spot.
The QS rankings are based on a series of qualitative measures. Academic reputation comprises 40 per cent of the ranking, with employer reputation comprising 10 per cent and quantitative measures of research excellence such as citations and staff H-indexes accounting for 50 per cent.
The 2017 QS assessment of Monash’s Pharmacy and Pharmacology subject included a perfect score of 100 for the academic reputation indicator, as well as strong scoring in citation metrics.
The Dean of the Faculty of Pharmacy and Pharmaceutical Sciences, Professor William Charman, said the ranking by QS was recognition of the faculty’s strong international reputation across research and undergraduate and post-graduate programs.
“Our consistently high ranking reflects the fabulous work being undertaken in education development, professional engagement and our many high impact, internationally-focused research programs,” Professor Charman said.
“Outcomes such as this are the result of a long-term strategic commitment to excellence by all our very talented professional, academic and research staff, postgraduate and undergraduate students,” Professor Charman said.
This outcome follows the recent recognition of seven MIPS researchers being named to the Thompson Reuters Hi-Ci list in pharmacology and toxicology, the highest number of Highly Cited Researchers in this field in the world.
It also echoes the most recent round of the Excellence in Research for Australia rankings, where Monash achieved the highest possible score of "5", meaning its research was well above world standard in the research discipline areas of Pharmacology and Pharmaceutical Sciences, Medicinal and Biomolecular Chemistry, and Nanotechnology.